BEC
LH icon

Blue Edge Capital’s Labcorp LH Stock Holding History

Blue Edge Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
750
-250
-25% -$65.7K 0.03% 133
2026
Q1 		$267K Buy
+1,000
New +$271K 0.04% 124

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Blue Edge Capital's LH Position: Q2 2026 in Review

Blue Edge Capital reduced its Labcorp (LH) stake by 25% in Q2 2026, selling an estimated $65.7K and leaving 750 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #133.

Blue Edge Capital first reported a position in LH in Q1 2026 and has held it in 2 quarters since. The position peaked at $267K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Blue Edge Capital held 750 shares of Labcorp worth $210K as of Q2 2026.
  • Blue Edge Capital sold 250 Labcorp shares in Q2 2026, an estimated $65.7K.
  • Labcorp made up 0.03% of Blue Edge Capital's portfolio in Q2 2026, its #133 holding.
  • Blue Edge Capital first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • Blue Edge Capital's Labcorp position peaked at $267K in Q1 2026.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Blue Edge Capital's 13F filing for Q2 2026, filed 17 Aug 2026.